COMMUNIQUÉS West-GlobeNewswire

Mike Murphy Joins Corizon Health as SVP of State Operations
07/08/2019
BRENTWOOD, Tenn., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Longtime corrections industry executive Michael E. Murphy has joined Corizon Health as senior vice president of state operations effective Aug. 1, the company [...]
Alphatec Advances InVictus™ MIS Spinal Fixation System With Commercial Launch of SingleStep™
07/08/2019
CARLSBAD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today [...]
CeCors, Inc. Establishes an Inside Sales Channel for Its Medical Records & Data Business
07/08/2019
LAS VEGAS, NV, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC PINK: CEOS) , a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is pleased to update [...]
AZTherapies Announces Appointment of Pharma Industry Veteran George D. Behrakis to its Board of Directors
07/08/2019
BOSTON, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc. , a biopharmaceutical company developing therapeutics to extend brain health, today announced that investor, former biopharmaceutical executive, and [...]
Nemaura Medical Announces First Shipments of SugarBEAT® Devices to Diabetic and Pre-Diabetic Patients as Part of its First Phase of Launch
07/08/2019
Reports strong pre-launch consumer interest with over 17,000 potential users that have signed up to receive product information prior to launch of official marketing campaign Loughborough, England, Aug. 07, 2019 (GLOBE [...]
Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina
07/08/2019
BASKING RIDGE, N.J. and MEMPHIS, Tenn., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company [...]
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
07/08/2019
Development of the waterfront office space and research facility by Alexandria Real Estate Equities, Inc. is underway with occupancy expected in 2021 SEATTLE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies [...]
TRACON Pharmaceuticals to Participate in the 2019 BTIG Biotechnology Conference
07/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
07/08/2019
WALTHAM, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to address the medical [...]
iTeos Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference
07/08/2019
iTeos Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference Gosselies, Belgium and Cambridge, MA – August 7, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel cancer [...]
Acasti Pharma Schedules First Quarter Fiscal 2020 Conference Call
07/08/2019
LAVAL, Québec, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
MyoKardia to Present at 2019 Wedbush PacGrow Healthcare Conference
07/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will present at the 2019 Wedbush PacGrow Healthcare Conference [...]
scPharmaceuticals Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
Type C Meeting confirmed that FDA does not believe additional clinical safety, efficacy, or pharmacology studies will be required to support NDA resubmission Company successfully completed the first of two planned human [...]
Progressive Care Inc. Garners Coverage in Hispanic MPR Podcast
07/08/2019
MIAMI, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that Shital Mars, CEO of Progressive Care Inc., was featured on [...]
TYME Announces Abstracts Selected for Presentation at the AACR Special Conference on Pancreatic Cancer
07/08/2019
SM-88 (racemetyrosine) is an oral, investigational cancer metabolism-based therapy that has demonstrated responses across 15 different cancers New oral approach aimed at disrupting cancer metabolism in metastatic [...]
Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial Results
07/08/2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer
07/08/2019
Dr. McHutchison is a world-renowned hepatologist, gastroenterologist, and anti-viral drug developer He led the research and development of five marketed therapies for chronic hepatitis B and chronic hepatitis C Succeeds [...]
Allena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
-- Interim Data from Study 206 Demonstrated Substantial Treatment Effect in Patients with Enteric Hyperoxaluria and Advanced Chronic Kidney Disease, Including Robust Reductions in Both Urine and Plasma Oxalate -- -- [...]
NeuBase Therapeutics to Ring the NASDAQ Closing Bell Today
07/08/2019
PITTSBURGH, Aug. 07, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” and the “Company”), a biotechnology company developing next generation antisense therapies to address genetic diseases, [...]

Pages